Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013–2014
Open Access
- 1 September 2016
- journal article
- research article
- Published by Springer Nature in Infectious Diseases of Poverty
- Vol. 5 (1) , 1-8
Abstract
H7N9 continues to cause human infections and remains a pandemic concern. Understanding the economic impacts of this novel disease is important for making decisions on health resource allocation, including infectious disease prevention and control investment. However, there are limited data on such impacts. Hospitalized laboratory-confirmed H7N9 patients or their families in Jiangsu Province of China were interviewed. Patients’ direct medical costs of hospitalization were derived from their hospital bills. A generalized linear model was employed to estimate the mean direct medical costs of patients with different characteristics. The mean direct cost of hospitalization for H7N9 was estimated to be ¥ 71 060 (95 % CI, 48 180–104 820), i.e., US$ 10 996 (95 % CI, 7 455–16 220), and was ¥12 060 (US$ 1 861), ¥136 120 (US$ 21 001) and ¥218 610 (US$ 33 728) for those who had mild or severe symptoms or who died, respectively. The principal components of the total fees differed among patients with different disease severity, although medication fees were always the largest contributors. Disease severity, proportion of reimbursement and family member monthly average income were identified as the key factors that contributed to a patient’s direct medical cost of hospitalization. The direct medical costs of hospitalized patients with H7N9 are significant, and far surpass the annual per capita income of Jiangsu Province, China. The influencing factors identified should be taken into account when developing related health insurance policies and making health resource allocation. Not applicable. This is a survey study with no health care intervention implemented on human participants.Keywords
Funding Information
- National Natural Science Foundation of China (81373055)
- Jiangsu Province Science and Technology Support Pro-gram (social development) (BE2012769)
- 10th Summit of Six Top Talents of Jiangsu Province (WS-2013-061)
- Jiangsu Province Science and Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention (BE2015714, BE2015714)
- Science and Technology Commission of Shanghai Municipality (14495810301)
This publication has 20 references indexed in Scilit:
- Clinical Features and Factors Associated with Outcomes of Patients Infected with a Novel Influenza A (H7N9) Virus: A Preliminary StudyPLOS ONE, 2013
- Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigationBMJ, 2013
- Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approachesMolecular BioSystems, 2013
- Clinical Findings in 111 Cases of Influenza A (H7N9) Virus InfectionNew England Journal of Medicine, 2013
- Direct Medical Cost of Influenza-Related Hospitalizations among Severe Acute Respiratory Infections Cases in Three Provinces in ChinaPLOS ONE, 2013
- Quantifying the economic burden of productivity loss in rheumatoid arthritisRheumatology, 2011
- How does the New Cooperative Medical Scheme influence health service utilization? A study in two provinces in rural ChinaBMC Health Services Research, 2010
- Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatmentHealth Policy, 2010
- Human Infection with Highly Pathogenic Avian Influenza Virus (H5N1) in Northern Vietnam, 2004–2005Emerging Infectious Diseases, 2009
- Critically Ill Patients With Severe Acute Respiratory SyndromeJAMA, 2003